Inhaled JAK Inhibitor GDC-0214 Reduces Exhaled Nitric Oxide in Patients with Mild Asthma

被引：0
|
作者：
Chen, H. [1 ]
Cai, F. [1 ]
Braithwaite, I. [2 ]
Tom, J. [1 ]
Galanter, J. M. [1 ]
McGregor, A. [1 ]
Zhu, R. [1 ]
Durk, M. R. [1 ]
Eliahu, A. [1 ]
Zak, M. [1 ]
Ghilardi, N. [1 ]
Rardin, H. [1 ]
Kenny, J. [1 ]
Wilson, M. [1 ]
Beasley, R. W. [2 ]
Owen, R. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Med Res Inst New Zealand, Wellington, New Zealand
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2020年 / 201卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4272
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhaled JAK inhibitor GDC-0214 reduces exhaled nitric oxide in patients with mild asthma: A randomized, controlled, proof-of-activity trial
    Braithwaite, Irene E.
    Cai, Fang
    Tom, Jennifer A.
    Galanter, Joshua M.
    Owen, Ryan P.
    Zhu, Rui
    Williams, Mathew
    McGregor, Anna G.
    Eliahu, Avi
    Durk, Matthew R.
    Dengler, Hart S.
    Zak, Mark
    Kenny, Jane R.
    Wilson, Maria E.
    Beasley, Richard
    Chen, Hubert
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (03) : 783 - 789
  • [2] Inhaled JAK inhibitor GDC-4379 reduces FeNO in patients with mild asthma
    Chen, Hubert
    Kunder, Rebecca
    Zou, Yixuan
    Gugelmann, Hallam
    Galanter, Joshua
    Zhu, Rui
    Owen, Ryan
    Staton, Tracy
    Wright, Matthew
    Durk, Matthew
    Eliahu, Avi
    Wilson, Maria
    Beasley, Richard
    Braithwaite, Irene
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Effects of inhaled JAK inhibitor GDC-4379 on exhaled nitric oxide and peripheral biomarkers of inflammation
    Chen, Hubert
    Kunder, Rebecca
    Zou, Yixuan
    Staton, Tracy
    Zhu, Rui
    Galanter, Joshua
    Gugelmann, Hallam
    Owen, Ryan
    Grimbaldeston, Michele A.
    Chang, Joanna K.
    Durk, Matthew R.
    Eliahu, Avi
    Wilson, Mark S.
    Choy, David F.
    Wilson, Maria
    Black, Melissa
    Doppen, Marjan
    Kung, Stacey
    Oldfield, Karen
    Sparks, Jenny
    Beasley, Richard
    Braithwaite, Irene
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 75
  • [4] Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing
    Moon, Chaeho
    Sahakijpijarn, Sawittree
    Maier, Esther Y.
    Taft, David R.
    Jara, Miguel O.
    Praphawatvet, Tuangrat
    Manandhar, Rachana
    Shetty, Nivedita
    Lubach, Joseph
    Narang, Ajit
    Nagapudi, Karthik
    Williams III, Robert O.
    [J]. MOLECULAR PHARMACEUTICS, 2024, 21 (02) : 564 - 580
  • [5] AZD4604, An Inhaled, Selective JAK1 Inhibitor Reduces Fractional Exhaled Nitric Oxide in Patients with Mild Asthma; A Randomized, Single-Blind Phase 1 Study
    Jensen, Tina Jellesmark
    Larsson, Julia
    Maenpaa, Jukka
    Mo, John
    Nemes, Szilard
    Riff, Camille
    Rojnik, Zala Jevnikar
    Zingmark, Pernilla
    Konstantinidis, Kyriakos
    Belvisi, Maria
    Keen, Christina
    Soto, Pablo Forte
    Chetty, Rajkumar
    Singh, Dave
    Hughes, Rod
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB98 - AB98
  • [6] Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma
    Silkoff, PE
    McClean, PA
    Slutsky, AS
    Caramori, M
    Chapman, KR
    Gutierrez, C
    Zamel, N
    [J]. JOURNAL OF ASTHMA, 1998, 35 (06) : 473 - 479
  • [7] Value of Fractional Exhaled Nitric Oxide in Diagnosing Mild Asthma Responsive to Inhaled Corticosteroids
    Karamarkovic Lazarusic, Natasa
    Kasap Basioli, Eugenija
    Tolic, Ena
    Dokoza, Martina
    Pavlisa, Gordana
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (09)
  • [8] Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma
    Kanniess, F
    Richter, K
    Böhme, S
    Jörres, RA
    Magnussen, H
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 2001, 14 (02) : 141 - 147
  • [9] A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled GDC-0214, a JAK1 Inhibitor, as Single- and Multiple-Ascending Doses in Healthy Volunteers
    Owen, Ryan
    Galanter, Joshua
    Zhu, Rui
    Cai, Fang
    Tom, Jennifer
    Wynne, Chris
    Durk, Matthew
    Chen, Liuxi
    Kenny, Jane
    She, Gao-hong
    Vadhavkar, Shweta
    Hwang, Olivia
    Chen, Hubert
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB17 - AB17
  • [10] Inhaled JAK Inhibitor GDC-0214 Nanoaggregate Powder Exhibits Improved Pharmacokinetic Profile in Rats Compared to the Micronized Form: Benefits of Thin Film Freezing (vol 21, pg 564, 2024)
    Moon, Chaeho
    Sahakijpijarn, Sawittree
    Maier, Esther Y.
    Taft, David R.
    Jara, Miguel O.
    Praphawatvet, Tuangrat
    Manandhar, Rachana
    Shetty, Nivedita
    Lubach, Joseph
    Narang, Ajit
    Nagapudi, Karthik
    Williams III, Robert O.
    [J]. MOLECULAR PHARMACEUTICS, 2024, 21 (06) : 3077 - 3077
12345